|Articles|November 1, 2017
Almac Group Announces Acquisition of BioClin Laboratories
Advertisement
Almac Group announced the acquisition of 100% shares of BioClin Laboratories. BioClin will bring fourth its expert analytical services and analysis to increase Almac’s capacity and compliment its existing business strategic expansion which will help them to serve clients globally.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research
2
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
3
From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee
4
ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy
5